Latest Transformation News

Amaero Ltd has secured A$50 million through a share placement and plans a further A$3 million via a Share Purchase Plan to fast-track growth initiatives aligned with U.S. defense and manufacturing re-shoring priorities.

Orbital Corporation reveals a strategic pivot amid evolving US drone policies, with a new management team driving growth beyond Boeing Insitu. FY25 guidance shows revenue decline but promising new contracts.

Objective Corporation reports robust FY2025 results with strong recurring revenue growth and deepening AI integration, setting ambitious targets for FY2026.

Objective Corporation reported solid FY2025 results with 5% revenue growth and a 15% jump in Annualised Recurring Revenue, underpinned by significant R&D investment and a strong subscription model.

Objective Corporation Limited reported a solid 5% revenue increase to $123.5 million and a 13% rise in net profit after tax to $35.44 million for FY2025, alongside a strategic acquisition that broadens its e-planning software portfolio.

RooLife Group Ltd (ASX, RLG) has launched its proprietary RLG Coffee brand in China, tapping into a rapidly expanding market with early sales exceeding $110,000 in the first month. Strategic partnerships and a recent supply deal position RLG for broader growth in the country’s evolving consumer landscape.

Castle Minerals has secured a 90% stake in Mineralis Ltd, gaining access to seven gold exploration permits in Côte d’Ivoire, complemented by a $3.3 million capital raise and a refreshed leadership team focused on West African growth.

Litchfield Minerals' recent VTEM survey at the Oonagalabi project has identified five conductor clusters with fourteen Priority 1 sulphide targets, setting the stage for a significant drilling campaign starting mid-September.

SkyCity Entertainment Group reports a 5% revenue decline in FY25 amid economic headwinds and elevated investments, announcing a $240 million equity raise to bolster its balance sheet ahead of the NZICC opening and online gaming launch.

Universal Store Holdings reported a robust FY25 with 15.5% revenue growth to $333.3 million, driven by strong like-for-like sales and new store openings. Despite a goodwill impairment in its CTC segment, the group declared a solid final dividend and advanced its sustainability agenda.

Tryptamine Therapeutics has secured an exclusive agreement with leading neuroscientists to develop a novel EEG-based brain entropy biomarker aimed at enhancing precision psychiatry for its psychedelic drug TRP-8803.

Downer EDI Limited reported a robust FY25 with a 33% rise in underlying NPATA and announced a $230 million share buy-back, underscoring confidence in its transformation and growth outlook. The company’s disciplined portfolio simplification and operational improvements set the stage for steady FY26 performance despite short-term market softness.